These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Topical clindamycin in acne vulgaris. Safety and stability. Algra RJ; Rosen T; Waisman M Arch Dermatol; 1977 Oct; 113(10):1390-1. PubMed ID: 143910 [TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris. Biswas S; Mondal KK; Dutta RN; Sarkar DK J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365 [TBL] [Abstract][Full Text] [Related]
29. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study. Hjorth N; Schmidt H; Thomsen K; Dela K Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900 [TBL] [Abstract][Full Text] [Related]
30. Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation. McKenzie MW; Beck DC; Popovich NG Arch Dermatol; 1981 Oct; 117(10):630-4. PubMed ID: 6456699 [TBL] [Abstract][Full Text] [Related]
31. Topical clindamycin in acne: a preliminary study. Panzer JD; Panzer JJ Cutis; 1979 Jul; 24(1):118-9. PubMed ID: 157850 [TBL] [Abstract][Full Text] [Related]
32. The safety of topical antibiotics in the treatment of acne vulgaris. Fisher AA Cutis; 1980 May; 25(5):474, 476, 481. PubMed ID: 6445813 [No Abstract] [Full Text] [Related]
33. Topical clindamycin in the control of acne vulgaris. Stoughton RB; Resh W Cutis; 1976 Mar; 17(3):551-4. PubMed ID: 138549 [No Abstract] [Full Text] [Related]
34. [Internal versus topical tetracycline therapy of acne]. Schwanitz HJ; Macher E Z Hautkr; 1984 Nov; 59(22):1515-21. PubMed ID: 6240166 [TBL] [Abstract][Full Text] [Related]
35. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. Shalita AR; Myers JA; Krochmal L; Yaroshinsky A; J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985 [TBL] [Abstract][Full Text] [Related]
36. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987 [TBL] [Abstract][Full Text] [Related]
37. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. Cunliffe WJ; Fernandez C; Bojar R; Kanis R; West F; J Dermatolog Treat; 2005; 16(4):213-8. PubMed ID: 16302325 [TBL] [Abstract][Full Text] [Related]
38. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels. Puhvel SM Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870 [TBL] [Abstract][Full Text] [Related]
39. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. Tanghetti E; Dhawan S; Torok H; Kircik L Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195 [TBL] [Abstract][Full Text] [Related]
40. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Al-Mishari MA Clin Ther; 1987; 9(3):273-80. PubMed ID: 2955899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]